Creo Medical Group PLC Tangible Net Worth Ratio
Creo Medical Group PLC tangible net worth ratio. Creo Medical Group PLC (CREO) has a Tangible Net Worth Ratio of 97.4% as of December 2025. This metric is calculated by deducting intangible assets (GBX1.30 Million) from net assets (GBX50.00 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Creo Medical Group PLC PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Creo Medical Group PLC (2007–2025)
Tangible net worth ratio of Creo Medical Group PLC from 2007 to 2025. This chart shows how Creo Medical Group PLC's Tangible Net Worth Ratio has changed across 16 annual periods from 2007 to 2025. As of December 2025, the ratio stands at 97.4%, reflecting net assets of GBX50.00 Million with intangible assets of GBX1.30 Million GBX. See CREO current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Creo Medical Group PLC Tangible Net Worth Ratio by Year (2007–2025)
Creo Medical Group PLC tangible net worth ratio by year from 2007 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Creo Medical Group PLC from 2007 to 2025, covering 16 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see how much is Creo Medical Group PLC worth.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.4% | GBX50.00 Million | GBX1.30 Million | GBX59.10 Million | ▼ -1.4 pp |
| 2024 | 98.8% | GBX42.40 Million | GBX500.00K | GBX65.00 Million | ▲ +10.7 pp |
| 2023 | 88.1% | GBX59.80 Million | GBX7.10 Million | GBX76.60 Million | ▲ +44.1 pp |
| 2022 | 44.0% | GBX49.40 Million | GBX27.64 Million | GBX75.34 Million | ▼ -18.8 pp |
| 2021 | 62.8% | GBX73.32 Million | GBX27.25 Million | GBX100.61 Million | ▲ +8.3 pp |
| 2020 | 54.6% | GBX62.81 Million | GBX28.53 Million | GBX92.46 Million | ▼ -44.4 pp |
| 2019 | 99.0% | GBX82.66 Million | GBX865.24K | GBX88.26 Million | ▼ -0.4 pp |
| 2018 | 99.4% | GBX47.71 Million | GBX307.81K | GBX49.75 Million | ▼ -0.5 pp |
| 2018 | 99.9% | GBX7.33 Million | GBX7.00K | GBX9.62 Million | ▼ 0.0 pp |
| 2017 | 99.9% | GBX14.65 Million | GBX10.90K | GBX16.12 Million | ▲ +0.7 pp |
| 2016 | 99.2% | GBX1.63 Million | GBX12.88K | GBX2.42 Million | ▼ -0.4 pp |
| 2016 | 99.6% | GBX3.22 Million | GBX12.88K | GBX3.75 Million | ▼ -0.4 pp |
| 2015 | 100.0% | GBX748.41K | GBX0.00 | GBX1.04 Million | ▲ +0.0 pp |
| 2014 | 100.0% | GBX1.37 Million | GBX0.00 | GBX1.62 Million | ▲ +0.0 pp |
| 2008 | 100.0% | GBX113.00K | GBX0.00 | GBX171.00K | ▲ +0.0 pp |
| 2007 | 100.0% | GBX12.00K | GBX0.00 | GBX257.00K | — |